Healthcare and Pharmaceutical Market in Pakistan
Description
Healthcare and Pharmaceutical Market in Pakistan
The pharmaceutical industry in Pakistan is growing at a rapid pace, contributing significantly to the national economy. In the last couple of years, the Pakistani economy has been suffering due to bad economic conditions and also been under strain due to the war against terrorism. The economy is also facing the problem of domestic inflation, slow economic growth, as well as the devaluation of the Pakistani rupee against other major currencies.
Pakistani pharmaceutical and healthcare industries are very competitive and challenging. There are nearly 600 pharmaceutical companies operating in Pakistan, with major global leaders having a presence in the country. The industry presents a lot of growth opportunities for drug makers, with the opportunities being driven by the rising burden of chronic disease and launch of the Pakistani national health insurance program.
However, there are many challenges that the industry faces, with regulatory and pricing challenges being at the top of the list. With the government's focus on boosting the pharmaceutical and healthcare market, the industry is poised for good growth, with many opportunities present for drawing in foreign investment.
In this industry scenario, Taiyou Research presents an analysis of the Healthcare and Pharmaceutical Market in Pakistan. The report analyzes the following points:
• Analysis of the healthcare and pharmaceutical market through an industry overview, overview of the healthcare segment, an overview of the pharmaceutical sector, the prevalence of diseases in Pakistan, industry drivers, investment, market distribution, healthcare expenditure, etc.
• Competition in the industry and generic players in Pakistan
• Major market activity by the leading drug makers
• Global trends and how the Pakistani industry compares
• SWOT analysis of the Pakistani healthcare and pharmaceutical market
• Regulatory landscape governing the industry in Pakistan
• A look at the industry research and development
• Industry challenges
• Forecast of the industry including a separate forecast for healthcare and pharmaceutical sector forecast
• Analysis of the major industry players with a company profile, presence in Pakistan, and a SWOT analysis
Taiyou Research’s report on the Healthcare and Pharmaceutical Market in Pakistan is a comprehensive coverage of the entire sector from 2012 till 2022.
The pharmaceutical industry in Pakistan is growing at a rapid pace, contributing significantly to the national economy. In the last couple of years, the Pakistani economy has been suffering due to bad economic conditions and also been under strain due to the war against terrorism. The economy is also facing the problem of domestic inflation, slow economic growth, as well as the devaluation of the Pakistani rupee against other major currencies.
Pakistani pharmaceutical and healthcare industries are very competitive and challenging. There are nearly 600 pharmaceutical companies operating in Pakistan, with major global leaders having a presence in the country. The industry presents a lot of growth opportunities for drug makers, with the opportunities being driven by the rising burden of chronic disease and launch of the Pakistani national health insurance program.
However, there are many challenges that the industry faces, with regulatory and pricing challenges being at the top of the list. With the government's focus on boosting the pharmaceutical and healthcare market, the industry is poised for good growth, with many opportunities present for drawing in foreign investment.
In this industry scenario, Taiyou Research presents an analysis of the Healthcare and Pharmaceutical Market in Pakistan. The report analyzes the following points:
• Analysis of the healthcare and pharmaceutical market through an industry overview, overview of the healthcare segment, an overview of the pharmaceutical sector, the prevalence of diseases in Pakistan, industry drivers, investment, market distribution, healthcare expenditure, etc.
• Competition in the industry and generic players in Pakistan
• Major market activity by the leading drug makers
• Global trends and how the Pakistani industry compares
• SWOT analysis of the Pakistani healthcare and pharmaceutical market
• Regulatory landscape governing the industry in Pakistan
• A look at the industry research and development
• Industry challenges
• Forecast of the industry including a separate forecast for healthcare and pharmaceutical sector forecast
• Analysis of the major industry players with a company profile, presence in Pakistan, and a SWOT analysis
Taiyou Research’s report on the Healthcare and Pharmaceutical Market in Pakistan is a comprehensive coverage of the entire sector from 2012 till 2022.
Table of Contents
95 Pages
- 1. Executive Summary
- 2. Healthcare and Pharmaceutical Market in Pakistan
- 2.1 Industry Overview
- 2.2 Healthcare Segment
- 2.3 Pharmaceutical Sector
- 2.4 Prevalence of Diseases in Pakistan
- 2.5 Industry Drivers
- 2.6 Industry Investment
- 2.7 Market Distribution
- 2.8 Healthcare Expenditure
- 2.9 Competition in the Industry
- 2.10 Generic Players in Pakistan
- 2.11 Market Activity by Major Drug Makers
- 2.12 Global Trends and how the Pakistani Industry Measures
- 3. Healthcare and Pharmaceutical Market in Pakistan: SWOT Analysis
- 3.1 Overview
- 3.2 Strengths
- 3.3 Weaknesses
- 3.4 Opportunities
- 3.5 Threats
- 4. Regulatory Landscape
- 4.1 Overview
- 4.2 Drug Pricing
- 4.3 Issue over Intellectual Property Rights
- 4.4 Reimbursement Policy
- 5. Industry Research and Development
- 5.1 Overview
- 5.2 Technology Adaptation in the Industry
- 5.3 Clinical Trials
- 5.4 Pharmaceutical R&D
- 6. Industry Challenges
- 6.1 No Health System Governance
- 6.2 No Health Equity in Pakistan
- 6.3 Lack of Resources and Poor Infrastructure
- 6.4 Other Challenges
- 7. Healthcare and Pharmaceutical Market in Pakistan: Forecast
- 7.1 Healthcare Forecast
- 7.2 Pharmaceutical Forecast
- 7.3 Future Trends
- 7.3.1 Healthcare Trends
- 7.3.2 Pharmaceutical Trends
- 8. Industry Players
- 8.1 Abbott Laboratories (Pakistan)
- 8.1.1 Company Profile
- 8.1.2 Presence in Pakistan
- 8.1.3 SWOT Analysis
- 8.2 Efroze Chemical Industries
- 8.2.1 Company Profile
- 8.2.2 Presence in Pakistan
- 8.2.3 SWOT Analysis
- 8.3 Ferozsons Laboratories
- 8.3.1 Company Profile
- 8.3.2 Presence in Pakistan
- 8.3.3 SWOT Analysis
- 8.4 Getz Pharma
- 8.4.1 Company Profile
- 8.4.2 Presence in Pakistan
- 8.4.3 SWOT Analysis
- 8.5 GlaxoSmithKline Pakistan
- 8.5.1 Company Profile
- 8.5.2 Presence in Pakistan
- 8.5.3 SWOT Analysis
- 8.6 Hilton Pharma
- 8.6.1 Company Analysis
- 8.6.2 Presence in Pakistan
- 8.6.3 SWOT Analysis
- 8.7 Novartis Pakistan
- 8.7.1 Company Profile
- 8.7.2 Presence in Pakistan
- 8.7.3 SWOT Analysis
- 8.8 Pfizer Pakistan Limited
- 8.8.1 Company Profile
- 8.8.2 Presence in Pakistan
- 8.8.3 SWOT Analysis
- 8.9 Sanofi-Aventis
- 8.9.1 Company Profile
- 8.9.2 Presence in Pakistan
- 8.9.3 SWOT Analysis
- 8.10 Pfizer Pakistan Limited
- 8.10.1 Company Profile
- 8.10.2 Presence in Pakistan
- 8.10.3 SWOT Analysis
- 8.11 SEARLE Company Limited
- 8.11.1 Company Profile
- 8.11.2 Presence in Pakistan
- 8.11.3 SWOT Analysis
- 9. Appendix
- 9.1 Health Indicators in Pakistan
- 9.2 State of Healthcare Infrastructure
- List of Figures
- Figure 1: Value of the Global Pharmaceutical Industry (in USD Million), 2017
- Figure 2: Burden of Disease Projection, 2005-2030
- Figure 3: Growth in the Pakistani Population, 1951-2011
- Figure 4: Population Distribution in Pakistan
- Figure 5: FDI in the Pakistani Pharmaceutical Industry (in USD Million), 2006-2016
- Figure 6: Health Expenditure to GDP in Pakistan, 1949-2016
- Figure 7: Public Health Expenditure in Pakistan and Other Countries as Percentage of GDP, 2015-2016
- Figure 8: Out of Pocket Expenditure on Health (as Percentage of Private Expenditure on Health)
- Figure 9: Registrations of Clinical Trials in Pakistan, 2013-2016
- Figure 10: Forecast of Healthcare Sector Expenditure, 2013-2027
- Figure 11: Forecast of Pharmaceutical Market, 2013-2027
- Figure 12: Forecast of Pharmaceutical Trade in Pakistan, 2013-2022
- Figure 13: Infant Mortality Rates per 1000 Live Births (Asian Countries), 1990-2016
- Figure 14: Life Expectancy at Birth in Years (Asian Countries), 1980-2015
- Figure 15: Growth in Index (%) of Health Establishments in Pakistan, 1991-2015
- Figure 16: Growth in Index (%) of Health Personnel in Pakistan, 1991-2015
- List of Tables
- Table 1: Healthcare Market in Pakistan, 2012-2017
- Table 2: Healthcare Resources in Pakistan, 2012-2017
- Table 3: Statistics on Healthcare Personnel in Pakistan, 2012-2017
- Table 4: Public Expenditure on Healthcare Sector (in Billion Rupees), 2015-2017
- Table 5: Leading Pharma Companies in Pakistan, 2018
- Table 6: Total Number of Pharmaceutical Companies in Pakistan, 1999, 2007, 2017
- Table 7: Pakistan Healthcare and Pharmaceuticals Forecast, 2016-2022
- Table 8: Trends in Healthcare Expenditure (Historical and Forecast), 2014-2022
- Table 9: Expenditure Trends Private Healthcare (Historical and Forecast), 2014-2022
- Table 10: Expenditure Trends Government Healthcare (Historical and Forecast), 2014-2022
- Table 11: Historical and Forecast of Pharmaceutical Sales in Pakistan, 2014-2022
- Table 12: Forecast for Pharmaceutical Trade in Pakistan, 2016-2022
- Table 13: Forecast for Pharmaceutical Trade in Pakistan (in Pakistan Rupees), 2016-2022
- Table 14: Infants Lacking Immunization in Pakistan, 2011-2014
- Table 15: Indicators of Child Growth for Children under 5 years of age in Pakistan, 1991-2012
- Table 16: Nurses and Midwives in Pakistan versus other Countries (per 1,000 people)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.